Spike S1 Rxxr
SARS CoV-2 IgG Spike S1 (CoV-2 IgG S1) Antibody |
|||
| abx137719-100tests | Abbexa | 100 tests | EUR 1237.5 |
Human IgG antibody Laboratories manufactures the spike s1 rxxr reagents distributed by Genprice. The Spike S1 Rxxr reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike S1. Other Spike products are available in stock. Specificity: Spike Category: S1 Group: Rxxr
Human MERS-COV Spike S1 Antibody IgG (MCSS1-IgG) ELISA Kit |
||
| MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Human MERS-COV Spike S1 Antibody IgG (MCSS1-IgG) ELISA Kit |
||
| MyBiosource | 48-Strip-Wells | EUR 550 |
Human MERS-COV Spike S1 Antibody IgG (MCSS1-IgG) ELISA Kit |
||
| MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Human MERS-COV Spike S1 Antibody IgG (MCSS1-IgG) ELISA Kit |
||
| MyBiosource | 96-Strip-Wells | EUR 765 |
Rabbit CoV-2 IgG S1 |
||
| ProSpec Tany | 50µg | EUR 900 |
|
Description: Recombinant Anti Rabbit SARS CoV-2 IgG Spike S1 |
||
True Blue |
||
| MedKoo Biosciences | 5.0mg | EUR 595 |
True Blue |
||
| MyBiosource | 5(mg | EUR 635 |
True Blue |
||
| MyBiosource | 5x5(mg | EUR 2705 |
True Blue |
||
| TargetMol Chemicals | 10mg | Ask for price |
|
Description: True Blue |
||
True Blue |
||
| TargetMol Chemicals | 1g | Ask for price |
|
Description: True Blue |
||
True Blue |
||
| TargetMol Chemicals | 1mg | Ask for price |
|
Description: True Blue |
||
True Blue |
||
| TargetMol Chemicals | 50mg | Ask for price |
|
Description: True Blue |
||
2019-nCoV Spike Protein S1 |
|||
| MBS515719-001mg | MyBiosource | 0.01mg | EUR 225 |
2019-nCoV Spike Protein S1 |
|||
| MBS515719-002mg | MyBiosource | 0.02mg | EUR 365 |
2019-nCoV Spike Protein S1 |
|||
| MBS515719-005mg | MyBiosource | 0.05mg | EUR 495 |
2019-nCoV Spike Protein S1 |
|||
| MBS515719-01mg | MyBiosource | 0.1mg | EUR 685 |
2019-nCoV Spike Protein S1 |
|||
| MBS515719-5x01mg | MyBiosource | 5x0.1mg | EUR 2825 |
2019-nCoV Spike Protein S1 |
|||
| MBS515720-001mg | MyBiosource | 0.01mg | EUR 290 |
2019-nCoV Spike Protein S1 |
|||
| MBS515720-002mg | MyBiosource | 0.02mg | EUR 365 |
2019-nCoV Spike Protein S1 |
|||
| MBS515720-005mg | MyBiosource | 0.05mg | EUR 495 |
2019-nCoV Spike Protein S1 |
|||
| MBS515720-01mg | MyBiosource | 0.1mg | EUR 685 |
2019-nCoV Spike Protein S1 |
|||
| MBS515720-5x01mg | MyBiosource | 5x0.1mg | EUR 2825 |
SARS CoV2 Spike S1 Antibody |
|||
| MBS669575-0025mg | MyBiosource | 0.025mg | EUR 220 |
SARS CoV2 Spike S1 Antibody |
|||
| MBS669575-01mg | MyBiosource | 0.1mg | EUR 400 |
SARS CoV2 Spike S1 Antibody |
|||
| MBS669575-5x01mg | MyBiosource | 5x0.1mg | EUR 1800 |
human anti-2019-nCoV Spike S1 mAb (S1) |
|||
| MBS8574745-01mg | MyBiosource | 0.1mg | EUR 705 |
human anti-2019-nCoV Spike S1 mAb (S1) |
|||
| MBS8574745-5x01mg | MyBiosource | 5x0.1mg | EUR 2910 |
Recombinant SARS MERS Spike S1 |
|||
| MBS141145-01mg | MyBiosource | 0.1mg | EUR 330 |
Recombinant SARS MERS Spike S1 |
|||
| MBS141145-05mg | MyBiosource | 0.5mg | EUR 825 |
Recombinant SARS MERS Spike S1 |
|||
| MBS141145-1mg | MyBiosource | 1mg | EUR 1515 |
Recombinant SARS MERS Spike S1 |
|||
| MBS141145-5x1mg | MyBiosource | 5x1mg | EUR 6485 |
Spike S1 Protein-His （Expi293） |
|||
| E24PNA002 | EnoGene | 2019-nCoV-Recombinant-Protein-Antigen,SARS-CoV-2-Spike-S1-Protein(His-Tag) | EUR 416.5 |
|
Description: 2019-nCoV Recombinant Protein Antigen,SARS-CoV-2 Spike S1 Protein (His Tag) |
|||
SARS MERS Spike S1 Recombinant |
|||
| rAP-5466 | Angio Proteomie | Inquiry | Ask for price |
MERS Spike S1 Recombinant protein |
|||
| 39-102 | ProSci | 0.1 mg | EUR 556.8 |
|
Description: Since April 2012, cases of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been identified in the following countries: Saudi Arabia, Qatar, Jordan, the United Arab Emirates, Oman, Kuwait, Yemen, Lebanon, Iran, Algeria, the United Kingdom, France, Italy, Greece, Germany, the Netherlands, Austria, Tunisia, Egypt, Malaysia, Turkey and the United States of America. Coronaviruses are the cause of the common cold, SARS (severe acute respiratory syndrome) and other severe illnesses with high mortality rates, all are classified into coronavirus family. MERS-CoV is a new type of SARS found in the coronavirus family causing severe pneumonia with sudden and serious respiratory illness with high mortality rates as well. Since January 27th 2015, the WHO has reported 956 human cases, including 351 deaths. More cases of the new coronavirus strain are expected. Like in other coronaviruses, large surface spike glycoprotein is a central structural protein of this virus; it is located above the virion surface to bind and enter into the target cell. Spike protein has 2 domains- S1 and S2. The S1 domain is responsible for cellular tropism and interaction with target cell, while the S2 domain is responsible for membrane fusion. The C-terminal of S1 domain contains a receptor binding domain, and is also a potential target for vaccine development and an antigen for diagnosis. |
|||
MERS Spike S1 Recombinant Protein |
|||
| MBS669387-01mg | MyBiosource | 0.1mg | EUR 500 |
MERS Spike S1 Recombinant Protein |
|||
| MBS669387-05mg | MyBiosource | 0.5mg | EUR 1010 |
MERS Spike S1 Recombinant Protein |
|||
| MBS669387-5x05mg | MyBiosource | 5x0.5mg | EUR 4525 |
COVID-19 Spike Glycoprotein-S1 |
|||
| MBS669370-005mg | MyBiosource | 0.05mg | EUR 1240 |
COVID-19 Spike Glycoprotein-S1 |
|||
| MBS669370-015mg | MyBiosource | 0.15mg | EUR 2610 |
COVID-19 Spike Glycoprotein-S1 |
|||
| MBS669370-5x015mg | MyBiosource | 5x0.15mg | EUR 11730 |